Using oligos printed on demand with enzymatic DNA synthesis accelerates Candida glabrata mutagenesis workflow
04 Nov 2021
This webinar will provide an overview of enzymatic DNA synthesis (EDS) and the core technology behind the SYNTAX System, the world’s first benchtop enzymatic DNA printer. The Pasteur Institute, an early adopter of the SYNTAX System, has leveraged EDS oligos for a variety of applications including rRNA depletion, COVID-19 research, and mutagenesis studies.
As an example of how oligos on demand can accelerate innovation, Dr. Colin Clairet, of the Pasteur Institute, will describe his current project involving mutant construction of the rising fungal pathogen Candida glabrata using SYNTAX oligos.
Key learning objectives
- Get an introduction to EDS and the SYNTAX System
- Hear a case study of how EDS and the SYNTAX accelerate innovation
- Discover the advantages of making on-demand DNA with enzymes
Who should attend?
- Genomic core facility managers
- Anybody who has ever waited on DNA to arrive to start an experiment
- Large-volume oligo users
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.